<?xml version="1.0" encoding="UTF-8"?>
<p>Phenolic compounds act in the same manner as NSAIDs, which are capable of reducing the chemical mediators of inflammation [
 <xref rid="B66-plants-10-00063" ref-type="bibr">66</xref>]. Here, dietary phenolics are connected to the inflammatory process and are associated with diseases that become potential targets to prevent these conditions [
 <xref rid="B67-plants-10-00063" ref-type="bibr">67</xref>]. The pathophysiology of certain forms of human cancer and inflammatory disorders was linked to the improper production of COX-2 and NO synthesis [
 <xref rid="B68-plants-10-00063" ref-type="bibr">68</xref>]. The curcumin from 
 <italic>C. longa</italic> was reported to reduce the IL-1β, IL-6, IL-8, MMP1, MMP3, MMP13 and TNF-α in human intervertebral disc cells [
 <xref rid="B38-plants-10-00063" ref-type="bibr">38</xref>]. In addition, UP1304 and curcumin I–III suppress the enzymatic action of COX and LOX [
 <xref rid="B34-plants-10-00063" ref-type="bibr">34</xref>,
 <xref rid="B40-plants-10-00063" ref-type="bibr">40</xref>]. A similar result was found when using petroleum ether, which is an alcohol extract of curcumin that reduces the metabolism of arachidonic acid and inhibits the production of COX, LOX, cytokines (ILs and TNF), and NF-κB [
 <xref rid="B42-plants-10-00063" ref-type="bibr">42</xref>].
</p>
